Senior Research Associate

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

E-pub date: 30 Sep 2020


ctDNA monitoring using patient-specific sequencing and integration of variant reads.

E-pub date: 31 May 2020


Detection of ctDNA from Dried Blood Spots after DNA Size Selection.

E-pub date: 31 Mar 2020


Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.

E-pub date: 31 Jan 2020


Improved ctDNA detection in early stage non-small-cell lung cancer

E-pub date: 01 Jul 2019


Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models.

E-pub date: 31 Oct 2018


Enhanced detection of circulating tumor DNA by fragment size analysis.

E-pub date: 31 Oct 2018


Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients.

E-pub date: 31 Jul 2018


Analytical validation of InVisionFirst (TM), a liquid biopsy assay for high-sensitivity broad molecular profiling of circulating tumor DNA using plasma samples of cancer patients

E-pub date: 01 Jul 2018


Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

E-pub date: 01 Jun 2018


Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

E-pub date: 16 Mar 2018


Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.

E-pub date: 15 Mar 2018


Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update

E-pub date: 01 Nov 2017


A pilot study of individualised monitoring of patients with metastatic melanoma using plasma and urine DNA.

E-pub date: 30 Apr 2017


Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.

E-pub date: 01 Apr 2017


Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

E-pub date: 31 Dec 2016


CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number changes.

E-pub date: 30 Apr 2016


Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer.

E-pub date: 30 Apr 2016


Evaluation of liquid biopsies for molecular profiling and monitoring in non-small cell lung cancer (NSCLC) patients.

E-pub date: 30 Apr 2016


Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.

E-pub date: 04 Nov 2015


Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform

E-pub date: 31 Jul 2015


Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform.

E-pub date: 30 Apr 2015


Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.

E-pub date: 01 Feb 2015


Proffered Paper: Noninvasive monitoring of tumour mutations and dynamics in circulating DNA of non-small cell lung cancer patients treated with EGFR inhibitors

E-pub date: 01 Jul 2014


Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.

E-pub date: 02 May 2013


Analysis of circulating tumor DNA to monitor metastatic breast cancer.

E-pub date: 28 Mar 2013


Non-invasive Monitoring of Metastatic Breast Cancer by Circulating Tumour DNA – a Comparison With Circulating Tumour Cells

E-pub date: 01 Jul 2012


Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

E-pub date: 30 May 2012


Show all
Research Integrity Conflict of Interest Disclosure: 
Last revised: 
27/03/2019
Company Active Research funding Ownership Royalty payments Commitment to carry out work for a fee Ad hoc reimbursed work Travel Gifts/ other
Inivata Ltd No No Yes No No No No No
Disclosure guidelines